Chicago · 100% Virtual
Prescription · Requires ConsultationWeight loss in Chicago, without losing the engine.
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending.
Elevate Chicago is a physician-led metabolic and hormone practice serving patients nationwide entirely by telehealth. Single- and dual-regulator GLP-1 protocols are written by the physician who read your labs — and built so what you lose is fat, not muscle.
Who this is for
- Patients who want meaningful fat loss without losing performance.
- Anyone with insulin resistance or metabolic syndrome markers.
- People who have plateaued on diet and training alone.
- Patients coming off a GLP-1 who want to hold the result.
Why most GLP-1 programs cost you muscle
GLP-1 medications work — and used without a plan they take muscle, strength and metabolic rate with the fat. A prescription mailed out after a two-minute questionnaire is not a protocol. Our metabolic protocols pair medication with protein targets, resistance training guidance and, where indicated, muscle-sparing peptides, so the number on the scale means something.
What your program includes
- Metabolic and insulin-resistance biomarker panel inside a 65-biomarker draw.
- GLP-1 or dual-agonist therapy titrated by a physician.
- Muscle-preservation strategy: protein, training and adjunct support.
- Body composition tracking, not just scale weight.
- Off-ramp planning so results hold after the medication.
Medications we work with
- Single Regulator (GLP-1) — semaglutide. Compounded formulations cannot be marketed under the drug's commercial name; the active ingredient is the same one found in FDA-approved products, but compounded formulations are not themselves FDA-approved.
- Dual Regulator (GLP-1/GIP) — tirzepatide. Compounded formulations cannot be marketed under the drug's commercial name; the active ingredient is the same one found in FDA-approved products, but compounded formulations are not themselves FDA-approved.
- Tesamorelin — FDA-approved, studied in visceral adipose tissue signaling.
- Muscle-sparing and metabolic adjuncts such as CJC-1295 + Ipamorelin, reviewed case by case.
Hormones decide how well weight loss works
Low testosterone, an under-treated thyroid, high cortisol or poor sleep will blunt any weight loss protocol and accelerate muscle loss during a calorie deficit. That is why the panel comes before the prescription. See hormone therapy in Chicago for that side of the work.
What the process looks like
- 01 — Apply and book. A $100 application fee reserves your intake and is credited toward your first order.
- 02 — Baseline labs. A 65-biomarker panel drawn at a Quest location near you — the Loop, Lincoln Park, Evanston, Naperville or Oak Brook.
- 03 — Physician video visit. Thirty minutes on every value, your training and your goals.
- 04 — Your protocol. Physician-designed, shipped to your door, with dosing and coaching built in.
- 05 — Ongoing optimization. Repeat Quest labs and continual titration as your biology changes.
Medications and sourcing
Prescribed therapies are dispensed through FDA-registered compounding pharmacies and licensed pharmacy partners when available. Research-use compounds, where offered, are a separate category — not FDA-approved, not prescribed as medical care, and not intended for human or animal consumption.
Frequently asked questions.
- How much weight do people actually lose on GLP-1 therapy?
- Published trials of semaglutide (single-regulator GLP-1) and tirzepatide (dual-regulator GLP-1/GIP) report average total body weight reductions in the mid-teens to low twenties percent over roughly a year and a half, on top of diet and activity change. Individual results vary widely, and the average is not a promise.
- How do you keep me from losing muscle?
- That is the reason for the lab panel and the protein-and-resistance-training requirement. Dose escalation is deliberately slower than the package titration when body composition is the goal, and follow-up labs track markers that move when lean mass is being burned instead of fat.
- What happens when I stop the medication?
- Appetite signaling returns and weight regain is common when nothing else has changed. The program is built around an exit: strength, protein intake and metabolic markers are worked on during therapy so that a maintenance dose or a taper is a real option rather than a cliff.
- What are the side effects?
- Nausea, constipation, reflux and early satiety are the common ones and are largely dose-dependent. Rarer but serious concerns — pancreatitis, gallbladder disease, and a contraindication in medullary thyroid carcinoma or MEN2 — are screened for before you are prescribed anything.
- Do I need to be diabetic to qualify?
- No. Eligibility is assessed on your full metabolic picture — BMI, waist, fasting insulin, HbA1c, lipids and hormone status — not on a diabetes diagnosis. Some people who ask about GLP-1s turn out to have a thyroid or hormone problem driving the weight instead, which is why the panel comes first.
Sources
- 1.Prescription medications to treat overweight and obesity— National Institute of Diabetes and Digestive and Kidney Diseases, NIH
- 2.Medications containing semaglutide marketed for type 2 diabetes or weight loss— U.S. Food & Drug Administration
- 3.FDA-approved prescribing information for semaglutide— DailyMed, U.S. National Library of Medicine
- 4.FDA-approved prescribing information for tirzepatide— DailyMed, U.S. National Library of Medicine
- 5.Test directory and patient service center locator— Quest Diagnostics
Related
Hormone therapy in Chicago
Physician-led testosterone, estradiol and thyroid work for Chicago patients, delivered entirely by video.
Peptide therapy in Chicago
How peptide protocols are built on top of a 65-biomarker baseline rather than sold off a menu.
Testosterone
The full picture behind one lab value — free testosterone, SHBG, estradiol and what monitoring requires.
About this page
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.
Next step
Find out what your numbers actually say.
A $100 application fee reserves your intake and is credited toward your first order. 65 biomarkers at Quest, then thirty minutes with your physician.
